Swiss National Bank’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-94,900
| Closed | -$293K | – | 2449 |
|
|
2024
Q4 | $293K | Buy |
94,900
+11,000
| +13% | +$34K | ﹤0.01% | 2432 |
|
|
2024
Q3 | $646K | Hold |
83,900
| – | – | ﹤0.01% | 2370 |
|
|
2024
Q2 | $720K | Buy |
83,900
+3,700
| +5% | +$31.7K | ﹤0.01% | 2309 |
|
|
2024
Q1 | $637K | Hold |
80,200
| – | – | ﹤0.01% | 2404 |
|
|
2023
Q4 | $794K | Sell |
80,200
-19,300
| -19% | -$191K | ﹤0.01% | 2358 |
|
|
2023
Q3 | $1.12M | Sell |
99,500
-15,700
| -14% | -$177K | ﹤0.01% | 2179 |
|
|
2023
Q2 | $382K | Buy |
115,200
+10,600
| +10% | +$35.2K | ﹤0.01% | 2577 |
|
|
2023
Q1 | $413K | Sell |
104,600
-12,300
| -11% | -$48.6K | ﹤0.01% | 2567 |
|
|
2022
Q4 | $848K | Buy |
116,900
+44,600
| +62% | +$323K | ﹤0.01% | 2421 |
|
|
2022
Q3 | $262K | Hold |
72,300
| – | – | ﹤0.01% | 2675 |
|
|
2022
Q2 | $328K | Sell |
72,300
-20,800
| -22% | -$94.4K | ﹤0.01% | 2704 |
|
|
2022
Q1 | $706K | Buy |
93,100
+6,400
| +7% | +$48.5K | ﹤0.01% | 2525 |
|
|
2021
Q4 | $948K | Buy |
+86,700
| New | +$948K | ﹤0.01% | 2501 |
|